NHS trusts contradict NHS England on Palantir data platform rollout

NHS England’s claim that 29 hospital trusts are using Palantir’s federated data platform (FDP) to realise benefits has been challenged by the trusts themselves. Responses to over 100 freedom of information requests reveal that many trusts say the system is not live or in use, despite the £330m contract’s April 2024 rollout. Regulators and lawmakers are now questioning the platform’s implementation and value.

Tarun Mottlia

Editor, Lazyfounder

Published Nov 3, 20263 min read

Image: Salvador Rios on Unsplash via source

KEY HIGHLIGHTS

NHS England lists 29 hospital trusts as "realising benefits" from Palantir’s £330m federated data platform (FDP), but the trusts say the system is not live or in use.
Over 100 freedom of information requests revealed the discrepancy, with trusts like Epsom and St Helier and Nottingham University Hospitals confirming no active use.
The Office for Statistics Regulation will review NHS England’s claim that 137 trusts are reporting benefits from the platform.
Chi Onwurah and the Commons health committee are urging the government to terminate Palantir’s contract and seek a UK-based supplier.

What NHS trusts reported

Freedom of information requests filed by medical charity Medact and shared with The Guardian show that 29 NHS trusts listed by NHS England as "realising benefits" from Palantir’s data platform are not using the system. Trusts such as Epsom and St Helier stated the platform was "not using FDP at the moment," while Nottingham University Hospitals confirmed "no implementation timeline has been agreed."

NHS England has previously stated that its list includes trusts using the platform for back-office data work, not direct patient care. However, the responses raise questions about how "benefits" are being measured and communicated.

NHS England’s defence and regulatory scrutiny

NHS England maintains that 142 trusts are live on the Palantir platform, with 137 reporting benefits. Its website acknowledges that its figures are based on before-and-after comparisons and "cannot draw conclusions about cause and effect."

The Office for Statistics Regulation will now review NHS England’s "realising benefits" claim. This follows calls from Chi Onwurah, chair of the Commons Science and Technology Committee, and the Commons health committee to terminate Palantir’s contract and seek a UK-based supplier.

Political and public pressure

Onwurah has urged the government to invoke a 2027 break clause in Palantir’s contract, citing transparency and national security concerns. In September, 44,000 people objected to the platform, reflecting broader public unease.

Palantir has responded to political pressure by hiring former Labour deputy leader Tom Watson as a lobbyist, a move that has drawn additional scrutiny.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

This dispute exposes the gap between top-down claims about large-scale public sector tech projects and the reality of adoption. For founders, it underscores the importance of aligning pilot expectations with end-user readiness—particularly in regulated sectors like healthcare. The political push to replace Palantir with a UK-based supplier could open doors for local startups, but only if they can demonstrate clearer implementation timelines and measurable benefits. The regulatory review of NHS England’s claims may also set a precedent for how governments assess and communicate the success of tech contracts, which could affect future procurement processes.

Key takeaways

Founders and operators in healthtech and public sector software should note the risks of misaligned expectations between centralised claims and on-the-ground adoption. This disconnect could undermine trust in large-scale digital transformation projects.
The push to replace Palantir with a UK-based supplier may create opportunities for local startups in healthcare data infrastructure, particularly those focused on transparency and compliance.
Regulatory scrutiny of benefit claims in public contracts could set a precedent for how governments evaluate and communicate the success of tech implementations.

Sources

The Next Web · 2026-11-02
29 NHS trusts said to benefit from Palantir don’t use it, Guardian reports

This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.

About the author